{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:34:05Z","timestamp":1777523645391,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T00:00:00Z","timestamp":1319673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2350-12-147","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T18:21:49Z","timestamp":1319739709000},"source":"Crossref","is-referenced-by-count":14,"title":["Genotype-phenotype correlations among BRCA14153delA and 5382insC mutation carriers from Latvia"],"prefix":"10.1186","volume":"12","author":[{"given":"Grigorijs","family":"Plakhins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvids","family":"Irmejs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andris","family":"Gardovskis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Signe","family":"Subatniece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santa","family":"Rozite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Bitina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guntars","family":"Keire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunta","family":"Purkalne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uldis","family":"Teibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genadijs","family":"Trofimovics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edvins","family":"Miklasevics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis","family":"Gardovskis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,27]]},"reference":[{"issue":"10","key":"880_CR1","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/jcp.2008.057950","volume":"61","author":"DS Tan","year":"2008","unstructured":"Tan DS, Marchi\u00f2 C, Reis-Filho JS: Hereditary breast cancer: from molecular pathology to tailored therapies. J Clin Pathol. 2008, 61 (10): 1073-1082. 10.1136\/jcp.2008.057950.","journal-title":"J Clin Pathol"},{"issue":"2","key":"880_CR2","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","volume":"3","author":"SJ Ramus","year":"2009","unstructured":"Ramus SJ, Gayther SA: The Contribution of BRCA1 and BRCA2 to Ovarian Cancer. Mol Oncol. 2009, 3 (2): 138-150. 10.1016\/j.molonc.2009.02.001.","journal-title":"Mol Oncol"},{"issue":"3","key":"880_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.molonc.2010.04.011","volume":"4","author":"N Mavaddat","year":"2010","unstructured":"Mavaddat N, Antoniou AC, Easton DF, Garcia-Closas M: Genetic susceptibility to breast cancer. Mol Oncol. 2010, 4 (3): 174-191. 10.1016\/j.molonc.2010.04.011.","journal-title":"Mol Oncol"},{"issue":"Spec No 2","key":"880_CR4","doi-asserted-by":"publisher","first-page":"R271","DOI":"10.1093\/hmg\/ddg258","volume":"12","author":"P Hohenstein","year":"2003","unstructured":"Hohenstein P, Fodde R: Of mice and (wo)men: genotype-phenotype correlations in BRCA1. Hum Mol Genet. 2003, 12 (Spec No 2): R271-7.","journal-title":"Hum Mol Genet"},{"key":"880_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1747-1028-3-1","volume":"3","author":"W Wu","year":"2008","unstructured":"Wu W, Koike A, Takeshita T, Ohta T: The ubiquitin E3 ligase activity of BRCA1 and its biological functions. Cell Division. 2008, 3: 1-10.1186\/1747-1028-3-1.","journal-title":"Cell Division"},{"issue":"4","key":"880_CR6","first-page":"329","volume":"11","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton D, Breast Cancer Linkage Consortium: Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev. 2002, 11 (4): 329-336.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"880_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1897-4287-8-8","volume":"8","author":"A Vanags","year":"2010","unstructured":"Vanags A, Strumfa I, Gardovskis A, et al: Population screening for hereditary and familial cancer syndromes in Valka district of Latvia. Hered Cancer Clin Pract. 2010, 8 (1): 8-10.1186\/1897-4287-8-8.","journal-title":"Hered Cancer Clin Pract"},{"issue":"2","key":"880_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10689-004-2758-3","volume":"4","author":"L Tikhomirova","year":"2005","unstructured":"Tikhomirova L, Sinicka O, Smite D, Eglitis J, Hodgson SV, Stengrevics A: High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia. Familial Cancer. 2005, 4 (2): 77-84. 10.1007\/s10689-004-2758-3.","journal-title":"Familial Cancer"},{"issue":"2","key":"880_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1897-4287-3-2-71","volume":"3","author":"A Gardovskis","year":"2005","unstructured":"Gardovskis A, Irmejs A, Miklasevics E, et al: Clinical, Molecular and Geographical Features of Hereditary Breast\/Ovarian Cancer in Latvia. Hered Cancer Clin Pract. 2005, 3 (2): 71-76. 10.1186\/1897-4287-3-2-71.","journal-title":"Hered Cancer Clin Pract"},{"issue":"2","key":"880_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10549-005-5150-6","volume":"94","author":"J Gronwald","year":"2005","unstructured":"Gronwald J, Elsakov P, G\u00f3rski B, Lubi\u0144ski J: High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families. Breast Cancer Res Treat. 2005, 94 (2): 111-113. 10.1007\/s10549-005-5150-6.","journal-title":"Breast Cancer Res Treat"},{"key":"880_CR11","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1086\/302922","volume":"66","author":"B Gorski","year":"2000","unstructured":"Gorski B, Byrski T, Huzarski T, et al: Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet. 2000, 66: 1963-1968. 10.1086\/302922.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"880_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1399-0004.2010.01404.x","volume":"78","author":"P Elsakov","year":"2010","unstructured":"Elsakov P, Kurtinaitis J, Petraitis S, et al: The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania. Clin Genet. 2010, 78 (4): 373-376. 10.1111\/j.1399-0004.2010.01404.x.","journal-title":"Clin Genet"},{"issue":"4","key":"880_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1399-0004.2010.01473.x","volume":"78","author":"NV Bogdanova","year":"2010","unstructured":"Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Hillemanns P, D\u00f6rk T: High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus. Clin Genet. 2010, 78 (4): 364-372. 10.1111\/j.1399-0004.2010.01473.x.","journal-title":"Clin Genet"},{"issue":"6","key":"880_CR14","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/ijc.11338","volume":"106","author":"J Menkiszak","year":"2003","unstructured":"Menkiszak J, Gronwald J, G\u00f3rski B, et al: Hereditary ovarian cancer in Poland. Int J Cancer. 2003, 106 (6): 942-945. 10.1002\/ijc.11338.","journal-title":"Int J Cancer"},{"issue":"12","key":"880_CR15","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1136\/jmg.2004.019430","volume":"41","author":"B Gorski","year":"2004","unstructured":"Gorski B, Menkiszak J, Gronwald J, Lubinski J, Narod SA: A protein truncating BRCA1 allele with a low penetrance of breast cancer. J Med Genet. 2004, 41 (12): e130-10.1136\/jmg.2004.019430.","journal-title":"J Med Genet"},{"issue":"12","key":"880_CR16","first-page":"3776","volume":"8","author":"JM Satagopan","year":"2002","unstructured":"Satagopan JM, Boyd J, Kauff ND, et al: Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations. Clin Cancer Res. 2002, 8 (12): 3776-3781.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"880_CR17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/jcp.2008.062646","volume":"62","author":"F Al-Mulla","year":"2009","unstructured":"Al-Mulla F, Bland JM, Serratt D, Miller J, Chu C, Taylor GT: Age-dependent penetrance of different germline mutations in the BRCA1 gene. J Clin Pathol. 2009, 62 (4): 350-356. 10.1136\/jcp.2008.062646.","journal-title":"J Clin Pathol"},{"key":"880_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2407-10-90","volume":"10","author":"L Cortesi","year":"2010","unstructured":"Cortesi L, Masini C, Cirilli C, et al: Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. BMC Cancer. 2010, 10: 90-10.1186\/1471-2407-10-90.","journal-title":"BMC Cancer"},{"issue":"1","key":"880_CR19","doi-asserted-by":"publisher","first-page":"R8","DOI":"10.1186\/bcr658","volume":"6","author":"ME Robson","year":"2004","unstructured":"Robson ME, Chappuis PO, Satagopan J, et al: A combined analysis of outcome following breast cancer: differences in survival based on BRCA1\/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res. 2004, 6 (1): R8-R17. 10.1186\/bcr658.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"880_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa070608","volume":"357","author":"G Rennert","year":"2007","unstructured":"Rennert G, Bisland-Naggan S, Barnett-Griness O, et al: Clinical Outcomes of Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations. N Engl J Med. 2007, 357 (2): 115-123. 10.1056\/NEJMoa070608.","journal-title":"N Engl J Med"},{"issue":"6","key":"880_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","volume":"22","author":"TR Rebbeck","year":"2004","unstructured":"Rebbeck TR, Friebel T, Lynch HT: Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group. J Clin Oncol. 2004, 22 (6): 1055-1062. 10.1200\/JCO.2004.04.188.","journal-title":"J Clin Oncol"},{"issue":"21","key":"880_CR22","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ: Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001, 93 (21): 1633-1637. 10.1093\/jnci\/93.21.1633.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"880_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/PPO.0b013e31819585f1","volume":"15","author":"ET Matloff","year":"2009","unstructured":"Matloff ET, Barnett RE, Bober SL: Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers. Cancer J. 2009, 15 (1): 15-18. 10.1097\/PPO.0b013e31819585f1.","journal-title":"Cancer J"},{"issue":"1","key":"880_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ogc.2010.03.003","volume":"37","author":"LP Shulman","year":"2010","unstructured":"Shulman LP: Hereditary Breast and Ovarian Cancer (HBOC): Clinical Features and Counseling for BRCA1 and BRCA2, Lynch Syndrome, Cowden Syndrome, and Li-Fraumeni Syndrome. Obstet Gynecol Clin North Am. 2010, 37 (1): 109-133. 10.1016\/j.ogc.2010.03.003.","journal-title":"Obstet Gynecol Clin North Am"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-12-147\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-12-147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,10]],"date-time":"2016-07-10T01:14:29Z","timestamp":1468113269000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-12-147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,27]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-12-147","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,27]]},"article-number":"147"}}